XOMAP FY 2024 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$28M+498.7% YoY

Gross Profit

$28M99.3% margin

Operating Income

-$40M-140.3% margin

Net Income

-$14M-48.5% margin

EPS (Diluted)

$-1.65

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$221M

Total Liabilities

$139M

Stockholders' Equity

$82M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$5M	+498.7%
Gross Profit	$28M	$5M	+512.8%
Operating Income	-$40M	-$42M	+4.5%
Net Income	-$14M	-$41M	+66.2%